Based on its proprietary LentiFlash® technology and Vectalys manufacturing platform, the company has potential to enable and advance the development of treatments mediated by RNA and DNA delivery for a broad range of diseases, including cancer, infectious disease and genetic diseases.
FLASH THERAPEUTICS
Adresse :
3 Avenue Hubert Curien Centre d'innovation Langlade31100 Toulouse
Catégorie : PME
Axe(s) métier : Médicament
Thématique(s) : Cardiométabolisme et risques associés | Dermatologie | Hématophilie | Infectiologie | Neurologie | Oncologie | Pneumologie
Pour plus de renseignements
Mme Pascale BOUILLE
pascale.bouille@flashtherapeutics.comhttps://www.flashtherapeutics.com/